Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Stagg

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Science (New York, N.Y.)|August 15, 2020
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapyLukas F Mager, Regula Burkhard, Nicola Pett, et al.
BMC Cancer|January 16, 2019
Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinomaHouda Bahig, Francine Aubin, John Stagg, et al.
Oncogene|February 19, 2026
The deubiquitinase USP17 regulates the expression and activity of the oncogenic driver β-catenin in colorectal cancerMariana Acevedo, Florence Dô, Firas El-Mortada, et al.
Cancer Research|September 13, 2015
CD73 is associated with poor prognosis in high-grade serous ovarian cancerMartin Turcotte, Kathleen Spring, Sandra Pommey, et al.
British Journal of Cancer|January 4, 2022
Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patternsNouredin Messaoudi, David Henault, David Stephen, et al.
Journal for Immunotherapy of Cancer|April 3, 2026
Targeting PAR-2 with a negative allosteric modulator increases tumor antigen presentation and potentiates anti-PD-1 immunotherapySamya Aouad, Maleck Kadiri, David Allard, et al.
Oncoimmunology|February 16, 2017
Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancerLaurence Buisseret, Soizic Garaud, Alexandre de Wind, et al.
Cancer Immunology Research|November 21, 2022
CD73 Inhibits cGAS-STING and Cooperates with CD39 to Promote Pancreatic CancerCélia Jacoberger-Foissac, Isabelle Cousineau, Yacine Bareche, et al.
JTO Clinical and Research Reports|December 3, 2024
CRYOVATE: A Pilot Study of Lung Cancer Cryoactivation in Combination With Immunotherapy in Advanced NSCLCAntoine Desilets, Gabryella Pinheiro, Wiam Belkaid, et al.
The Journal of Clinical Investigation|February 7, 2017
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacyPaul A Beavis, Melissa A Henderson, Lauren Giuffrida, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Science (New York, N.Y.)|August 15, 2020
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapyLukas F Mager, Regula Burkhard, Nicola Pett, et al.
BMC Cancer|January 16, 2019
Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinomaHouda Bahig, Francine Aubin, John Stagg, et al.
Oncogene|February 19, 2026
The deubiquitinase USP17 regulates the expression and activity of the oncogenic driver β-catenin in colorectal cancerMariana Acevedo, Florence Dô, Firas El-Mortada, et al.
Cancer Research|September 13, 2015
CD73 is associated with poor prognosis in high-grade serous ovarian cancerMartin Turcotte, Kathleen Spring, Sandra Pommey, et al.
British Journal of Cancer|January 4, 2022
Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patternsNouredin Messaoudi, David Henault, David Stephen, et al.
Journal for Immunotherapy of Cancer|April 3, 2026
Targeting PAR-2 with a negative allosteric modulator increases tumor antigen presentation and potentiates anti-PD-1 immunotherapySamya Aouad, Maleck Kadiri, David Allard, et al.
Oncoimmunology|February 16, 2017
Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancerLaurence Buisseret, Soizic Garaud, Alexandre de Wind, et al.
Cancer Immunology Research|November 21, 2022
CD73 Inhibits cGAS-STING and Cooperates with CD39 to Promote Pancreatic CancerCélia Jacoberger-Foissac, Isabelle Cousineau, Yacine Bareche, et al.
JTO Clinical and Research Reports|December 3, 2024
CRYOVATE: A Pilot Study of Lung Cancer Cryoactivation in Combination With Immunotherapy in Advanced NSCLCAntoine Desilets, Gabryella Pinheiro, Wiam Belkaid, et al.
The Journal of Clinical Investigation|February 7, 2017
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacyPaul A Beavis, Melissa A Henderson, Lauren Giuffrida, et al.
Pageof 11